Viridian Therapeutics, Inc. (VRDN) Ownership

$19.81

$1.09 (5.82%)
Last update: 04:00 PM EST
Day's range
$18.63
Day's range
$19.82

Viridian Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/14/2025 12.24 M $171.10 M   0.13% 15.00%
BLACKROCK, INC. 08/12/2025 5.52 M $77.18 M   -3.28% 6.77%
DEEP TRACK CAPITAL, LP 08/14/2025 5.38 M $75.22 M   0.00% 6.59%
COMMODORE CAPITAL LP 08/14/2025 4.88 M $68.15 M   35.42% 5.97%
VANGUARD GROUP INC 08/11/2025 4.51 M $63.03 M   -1.20% 5.53%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2025 4.43 M $61.90 M   -5.79% 5.43%
VR ADVISER, LLC 08/14/2025 3.88 M $54.28 M   0.00% 4.76%
FAIRMOUNT FUNDS MANAGEMENT LLC 08/14/2025 3.46 M $48.37 M   0.41% 4.24%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 2.90 M $40.48 M   71.51% 3.55%
TANG CAPITAL MANAGEMENT LLC 08/14/2025 2.84 M $39.74 M   1.79% 3.48%
PARADIGM BIOCAPITAL ADVISORS LP 08/14/2025 2.74 M $38.33 M   30.86% 3.36%
STATE STREET CORP 08/14/2025 2.55 M $35.70 M   -10.89% 3.13%
NOVO HOLDINGS A/S 08/14/2025 2.38 M $33.27 M   5.76% 2.92%
MAVERICK CAPITAL LTD 08/14/2025 2.26 M $31.55 M   9.50% 2.77%
ALLIANCEBERNSTEIN L.P. 08/14/2025 1.94 M $27.18 M   -3.84% 2.38%
EVERSEPT PARTNERS, LP 08/14/2025 1.90 M $26.60 M   38.10% 2.33%
BAKER BROS. ADVISORS LP 08/14/2025 1.74 M $24.39 M   100.00% 2.14%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 1.74 M $24.34 M   1.17% 2.13%
LOOMIS SAYLES & CO L P 08/13/2025 1.34 M $18.71 M   -2.33% 1.64%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2025 1.30 M $18.16 M   22.01% 1.59%
PICTET ASSET MANAGEMENT HOLDING SA 08/13/2025 1.27 M $17.70 M   1.36% 1.55%
MARSHALL WACE, LLP 08/13/2025 1.21 M $16.89 M   11.42% 1.48%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2025 1.11 M $15.50 M   -0.54% 1.36%
VIVO CAPITAL, LLC 08/14/2025 982.58 K $13.74 M   0.00% 1.20%
GOLDMAN SACHS GROUP INC 08/14/2025 899.83 K $12.58 M   -26.91% 1.10%
CANDRIAM S.C.A. 08/08/2025 862.27 K $12.06 M   -2.06% 1.06%
WOODLINE PARTNERS LP 08/14/2025 815.49 K $11.40 M   0.23% 1.00%
5AM VENTURE MANAGEMENT, LLC 08/14/2025 736.60 K $10.30 M   0.00% 0.90%
ROSALIND ADVISORS, INC. 08/14/2025 700.00 K $9.79 M   17.65% 0.86%
CITADEL ADVISORS LLC 08/14/2025 649.54 K $9.08 M   633.56% 0.80%
NORTHERN TRUST CORP 08/13/2025 596.88 K $8.34 M   -15.04% 0.73%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 574.02 K $8.02 M   1.42% 0.70%
VICTORY CAPITAL MANAGEMENT INC 08/13/2025 564.79 K $7.90 M   2.16% 0.69%
UBS GROUP AG 08/14/2025 533.64 K $7.46 M   5.84% 0.65%
RICE HALL JAMES & ASSOCIATES, LLC 08/11/2025 515.62 K $7.21 M   42.09% 0.63%
FISHER ASSET MANAGEMENT, LLC 08/13/2025 509.96 K $7.13 M   -5.04% 0.63%
YIHENG CAPITAL MANAGEMENT, L.P. 08/14/2025 500.26 K $6.99 M   0.00% 0.61%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 485.70 K $6.79 M   100.00% 0.60%
HIGHVISTA STRATEGIES LLC 08/14/2025 484.56 K $6.77 M   168.38% 0.59%
IKARIAN CAPITAL, LLC 08/14/2025 469.95 K $6.57 M   -5.05% 0.58%
PERCEPTIVE ADVISORS LLC 08/14/2025 447.51 K $6.26 M   -32.16% 0.55%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 07/25/2025 423.27 K $5.92 M   0.00% 0.52%
JPMORGAN CHASE & CO 08/12/2025 415.99 K $5.82 M   39.34% 0.51%
AFFINITY ASSET ADVISORS, LLC 08/13/2025 390.00 K $5.45 M   0.00% 0.48%
DEUTSCHE BANK AG\ 08/12/2025 386.94 K $5.41 M   -2.49% 0.47%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2025 376.85 K $5.27 M   -70.34% 0.46%
PANAGORA ASSET MANAGEMENT INC 08/13/2025 351.85 K $4.92 M   -0.81% 0.43%
ROYAL BANK OF CANADA 08/14/2025 345.90 K $4.84 M   162,293.43% 0.42%
RAYMOND JAMES FINANCIAL INC 08/14/2025 332.09 K $4.64 M   4.35% 0.41%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 270.54 K $3.78 M   8.58% 0.33%

Viridian Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 215 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 12.24 M

BlackRock, Inc.: 5.52 M

Deep Track Capital, LP: 5.38 M

COMMODORE CAPITAL LP: 4.88 M

VANGUARD GROUP INC: 4.51 M

Kynam Capital Management, LP: 4.43 M

115.89% of Viridian Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 101.98 M shares in the last 24 months. This purchase volume represents approximately $2.02 B in transactions.